text: Check it out, y'all, I got a story to tell,
  'Bout immune checkpoint inhibitors, they ringin' the bell,
  These antibodies target immune checkpoints, you see,
  CTLA-4, PD-1, PD-L1, they the key.
  
  Oncologists got a new tool in their hand,
  ICIs fight cancer, they takin' a stand,
  But these therapies come with a price,
  Autoimmune adverse effects, ain't that nice?
  
  Hypophysitis, thyroid dysfunction, and diabetes too,
  Primary adrenal insufficiency, it's all true,
  Autoimmune polyendocrine syndrome type 2 might appear,
  When you're on ICIs, watch out, it's clear.
  
  This article's all about the facts and the stats,
  The role of ICs, how they affectin' the mats,
  Treating different cancers with ICIs, that's the goal,
  But don't forget the endocrine complications, it takes its toll.
  
  Screenin' and managin' patients, that's what we need,
  To handle these endocrinopathies, indeed,
  In everyday clinical practice, we gotta be aware,
  Of the risks and the challenges, showin' we care.